1 |
Paskeh MDA, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, Saleki H, Sharifzadeh SO, Far FB, Ashrafizadeh M, Samarghandian S, Khan H, Ghavami S, Zarrabi A, Łos MJ. Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166326. [DOI: 10.1016/j.bbadis.2021.166326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Zhou P, Li J, Chen Q, Wang L, Yang J, Wu A, Jiang N, Liu Y, Chen J, Zou W, Zeng J, Wu J. A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications. Front Pharmacol 2021;12:750165. [PMID: 34616302 DOI: 10.3389/fphar.2021.750165] [Reference Citation Analysis]
|
3 |
Zhang W, Peng C, Shen X, Yuan Y, Zhang W, Yang C, Yao M. A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells. Molecules 2021;26:3843. [PMID: 34202548 DOI: 10.3390/molecules26133843] [Reference Citation Analysis]
|
4 |
Zuo Q, Liao L, Yao ZT, Liu YP, Wang DK, Li SJ, Yin XF, He QY, Xu WW. Targeting PP2A with lomitapide suppresses colorectal tumorigenesis through the activation of AMPK/Beclin1-mediated autophagy. Cancer Lett 2021;521:281-93. [PMID: 34509534 DOI: 10.1016/j.canlet.2021.09.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|